Comgest Global Investors S.A.S. Buys 13,030 Shares of Relx Plc (NYSE:RELX)

Comgest Global Investors S.A.S. lifted its stake in shares of Relx Plc (NYSE:RELX) by 30.8% in the fourth quarter, HoldingsChannel reports. The fund owned 55,284 shares of the technology company’s stock after acquiring an additional 13,030 shares during the period. Comgest Global Investors S.A.S.’s holdings in Relx were worth $2,511,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Private Trust Co. NA increased its stake in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after purchasing an additional 199 shares in the last quarter. Sage Mountain Advisors LLC increased its stake in Relx by 5.1% in the 4th quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock worth $240,000 after buying an additional 258 shares in the last quarter. DRW Securities LLC raised its holdings in Relx by 5.9% during the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company’s stock valued at $211,000 after acquiring an additional 259 shares during the period. Peapack Gladstone Financial Corp raised its holdings in Relx by 5.7% during the third quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company’s stock valued at $234,000 after acquiring an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc lifted its position in shares of Relx by 1.3% in the fourth quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock valued at $1,190,000 after acquiring an additional 325 shares in the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Relx Stock Performance

NYSE RELX opened at $49.06 on Monday. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a 1-year low of $40.25 and a 1-year high of $51.99. The business has a 50 day simple moving average of $49.29 and a two-hundred day simple moving average of $47.87. The stock has a market capitalization of $90.79 billion, a PE ratio of 26.37, a P/E/G ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is a boost from Relx’s previous semi-annual dividend of $0.23. Relx’s payout ratio is currently 59.68%.

Analyst Upgrades and Downgrades

RELX has been the topic of several recent analyst reports. Redburn Atlantic began coverage on Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock. The Goldman Sachs Group started coverage on shares of Relx in a research report on Wednesday, March 26th. They set a “buy” rating on the stock. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.